ASX Share rice
Sun 16 Aug 2020 - 02:20:am (Sydney)

ANR Share Price

ANATARA LIFESCIENCES LTDANRPharmaceuticals, Biotechnology & Life Sciences

ANR Company Information

Name:

Anatara Lifesciences Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

62 Lygon Street Carlton Australia 3053

Phone:

61 7 3394 8202

Chief Exec. Officer:

Mr. Steven Lydeamore CPA, M.B.A., MBA, CPA

Chief Operating Officer:

Dr. Michael L. West

Managing Director of IR Department:

Jane Lowe

Company Sec.:

Dr. Stephen Denaro BCom, GradDipApp CG, CA, MAICD

Commercial Mang.:

Ms. Hayley van der Meer B Biomed Sc, Grad Dip Marketing Management

Company Overview:

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia. Its lead product includes Detach, a non-antibiotic therapy that prevents and treats diarrhea disease in piglets. The company is also developing bromelain formulations for gastrointestinal health. Anatara Lifesciences Limited is based in Carlton, Australia.

ANR Share Price Information

Shares Issued:

49.86M

Market Capitalisation:

$6.73M

Revenue (TTM):

$594.14K

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.058

Operating Margin (TTM):

$-4.64

Return On Assets (TTM):

$-0.27

Return On Equity (TTM):

$-0.49

Quarterly Revenue Growth (YOY):

-0.142

Gross Profit(TTM):

$-112,851

Diluted Earnings Per Share (TTM):

$-0.054

ANR CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$2.34M

Change To Liabilities:

$-54,962

Total Cashflow From Investing Activities:

$2.34M

Net Income:

$-2,868,272

Total Cash From Operating Activities:

$-2,426,317

Depreciation:

$22.73K

Other Cashflow From Investing Activities:

$188.66K

Change To Account Receivables:

$1.10M

Capital Expenditures:

$0

ANR Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,868,272

Net Income:

$-2,868,272

Gross Profit:

$663.41K

Operating Income:

$-3,818,739

Other Operating Expenses:

$-877,573

Total Revenue:

$663.41K

Total Operating Expenses:

$4.48M

Cost Of Revenue:

$776.26K

ANR Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$7.05K

Total Liabilities:

$466.76K

Total Stockholder Equity:

$5.92M

Other Current Liabilities:

$33.17K

Total Assets:

$6.38M

Common Stock:

$16.94M

Other Current Assets:

$49.02K

Retained Earnings:

$-11,524,895

Other Liabilities:

$13.94K

Cash:

$1.36M

Total Current Liabilities:

$452.82K

Property - Plant & Equipment:

$20.20K

Net Tangible Assets:

$5.91M

Total Current Assets:

$6.36M

Net Receivables:

$895.99K

Short-Term Investments:

$27.24K

Accounts Payable:

$116.76K

Non Currrent Assets (Other):

$27.24K

Short-Term Investments:

$27.24

Non Current Liabilities Total:

$13.94K

ANR Share Price History

ANR News

05 Apr, 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
31 Dec, 2019
Anatara Lifesciences Limited (ASX:ANR) shareholders should be happy to see the share price up 20% in the last month...
28 Oct, 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
13 Sep, 2019
A look at the shareholders of Anatara Lifesciences Limited (ASX:ANR) can tell us which group is most powerful...